About us
Team
Supervisory Board
Scientific Advisory Board
Technology
Pipeline
Investors
Career
News & Events
Contact us
Menu
About us
Team
Supervisory Board
Scientific Advisory Board
Technology
Pipeline
Investors
Career
News & Events
Contact us
About us
Team
Supervisory Board
Scientific Advisory Board
Technology
Pipeline
Investors
Career
News & Events
Contact us
About us
Team
Supervisory Board
Scientific Advisory Board
Technology
Pipeline
Investors
Career
News & Events
Contact us
Imprint
Privacy Statement
Disclaimer
Imprint
Privacy Statement
Disclaimer
News & Events
News
Our latest Press Releases
Gilead and Tubulis Enter into Exclusive Option and Licence Agreement to Develop ADC Candidate for Select Solid Tumor Target
December 3, 2024
Fierce Biotech Names Tubulis a “Fierce 15” Biotech Company of 2024
August 5, 2024
Tubulis Receives FDA Fast Track Designation for Antibody-Drug Conjugate Candidate TUB-040 in Platinum-resistant Ovarian Cancer
June 27, 2024
More News
EVENTS
Meet Tubulis live
Presentation
J.P. Morgan Health Care Conference, San Francisco
January 13-16, 2025
Participation
ESGO 2025 Congress, Rome
February 20-23, 2025
Participation
15th Annual World ADC, London
March 3-6, 2025
Presentation
4th Novel Conjugates Summit, Boston
March 25-27, 2025
More Events